{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:06:24Z","timestamp":1784865984703,"version":"3.55.0"},"reference-count":34,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031641","name":"Information Technology and Innovation Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100031641","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Leibniz Science Campus Ruhr, Essen Germany"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Policy and Practice"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/20523211.2025.2472221","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T08:51:16Z","timestamp":1741251076000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Prevalence and relationship with health of off-label and contraindicated drug use in the United States: a cross-sectional study"],"prefix":"10.1080","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9831-1787","authenticated-orcid":false,"given":"Katharina E.","family":"Blankart","sequence":"first","affiliation":[{"name":"University of Duisburg-Essen","place":["Essen, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5113-9681","authenticated-orcid":false,"given":"Frank R.","family":"Lichtenberg","sequence":"additional","affiliation":[{"name":"Columbia University in the City of New York","place":["New York, USA"]},{"name":"National Bureau of Economic Research","place":["Cambridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,3,6]]},"reference":[{"key":"e_1_3_8_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa997"},{"key":"e_1_3_8_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac1085"},{"key":"e_1_3_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.econlet.2017.06.028"},{"key":"e_1_3_8_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/joie.12189"},{"key":"e_1_3_8_6_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200528010-00005"},{"key":"e_1_3_8_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/ectj.12097"},{"key":"e_1_3_8_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e3181a23e3a"},{"key":"e_1_3_8_9_1","unstructured":"Definition of contraindication \u2013 NCI dictionary of cancer terms \u2013 NCI (nciglobal ncienterprise). (2011 February 2). [nciAppModulePage]. https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/contraindication"},{"key":"e_1_3_8_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.6058"},{"key":"e_1_3_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2018.08.002"},{"key":"e_1_3_8_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.300.4.379"},{"key":"e_1_3_8_13_1","unstructured":"Food and Drug Administration. (2023 February 8). Drugs@FDA Glossary of terms. FDA. https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/drugsfda-glossary-terms"},{"key":"e_1_3_8_14_1","doi-asserted-by":"publisher","DOI":"10.1215\/03616878-6951103"},{"key":"e_1_3_8_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.0380"},{"key":"e_1_3_8_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-13-1"},{"key":"e_1_3_8_17_1","doi-asserted-by":"publisher","DOI":"10.1257\/000282803321946985"},{"key":"e_1_3_8_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.4506"},{"key":"e_1_3_8_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1435-5957.2007.00130.x"},{"key":"e_1_3_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2016.02.007"},{"key":"e_1_3_8_21_1","volume-title":"Drugs approved for different types of cancer","author":"National Cancer Institute","year":"2024","unstructured":"National Cancer Institute. (2024). Drugs approved for different types of cancer. https:\/\/www.cancer.gov\/about-cancer\/treatment\/drugs\/cancer-type."},{"key":"e_1_3_8_22_1","unstructured":"National Library of Medicine. (2024). SNOMED CT to ICD-10-CM map [Dataset]. https:\/\/www.nlm.nih.gov\/research\/umls\/mapping_projects\/snomedct_to_icd10cm.html"},{"key":"e_1_3_8_23_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-4060"},{"key":"e_1_3_8_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.9.1021"},{"key":"e_1_3_8_25_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-publhealth-031912-114353"},{"key":"e_1_3_8_26_1","doi-asserted-by":"publisher","DOI":"10.1377\/hpb20160630.920075"},{"key":"e_1_3_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2016.07.005"},{"key":"e_1_3_8_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/hec.3537"},{"key":"e_1_3_8_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/zxad086"},{"key":"e_1_3_8_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky963"},{"key":"e_1_3_8_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw993"},{"key":"e_1_3_8_32_1","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) & Center for Biologics Evaluation and Research (CBER). (2011). Guidance for industry \u2013 warnings and precautions contraindications and boxed warning sections of labeling for human prescription drug and biological products \u2013 content and format. https:\/\/www.fda.gov\/media\/71866\/download"},{"key":"e_1_3_8_33_1","unstructured":"US Food and Drug Administration. (2019 April 18). Understanding unapproved use of approved drugs \u201coff label\u201d. FDA. https:\/\/www.fda.gov\/patients\/learn-about-expanded-access-and-other-treatment-options\/understanding-unapproved-use-approved-drugs-label"},{"key":"e_1_3_8_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40258-022-00751-y"},{"key":"e_1_3_8_35_1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028018765159"}],"container-title":["Journal of Pharmaceutical Policy and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/20523211.2025.2472221","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T13:13:40Z","timestamp":1765890820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/20523211.2025.2472221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,6]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/20523211.2025.2472221"],"URL":"https:\/\/doi.org\/10.1080\/20523211.2025.2472221","relation":{},"ISSN":["2052-3211"],"issn-type":[{"value":"2052-3211","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=jppp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=jppp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-11-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2472221"}}